Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Advances in Laboratory Methods for Detection and Typing of Norovirus
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Multimodal approach to control postoperative pathophysiology and rehabilitation
1997 Standout
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
2004
Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function
2000
Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: A pilot study
2005
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
2012 Standout
Review article: hepatitis B and liver transplantation
2006
Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome
1996
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts
2011
Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells
2012
Hepatitis C and liver transplantation
2005 Nature
The influence of glucan polymer structure and solution conformation on binding to (1->3)- -D-glucan receptors in a human monocyte-like cell line
2000
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience
2008
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
HELICAL CT GRADING OF TRAUMATIC AORTIC INJURIES
1999
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: Report of two successful cases
2005
Nutrition for the liver transplant patient
2006
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
2006
Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen–positive liver donation: A survey of North American, European, and Asian-Pacific transplant programs
2009
Hepatitis B virus infection
2009 Standout
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation
2004 StandoutNobel
Severe Sepsis and Septic Shock
2013 Standout
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Macrophages play an essential role in trauma-induced sterile inflammation and tissue repair
2018
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Immunostimulatory properties and antitumor activities of glucans
2013
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Guidelines for the Diagnosis and Management of Blunt Aortic Injury: An EAST Practice Management Guidelines Work Group
2000
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
2004
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
2005
Pros and Cons: Usage of organs from donors infected with hepatitis C virus – Revision in the direct-acting antiviral era
2015
Treating hepatitis C
2005 StandoutNobel
Sepsis: A New Hypothesis for Pathogenesis of the Disease Process
1997
Chronic hepatitis B
2007 Standout
Sir Isaac Newton, sepsis, SIRS, and CARS
1996 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Structure–function relationships of immunostimulatory polysaccharides: A review
2015 Standout
Type 1 diabetes
2013 Standout
Rapamycin Causes Upregulation of Autophagy and Impairs Islets Function Both In Vitro and In Vivo
2011
Treatment of hepatitis C
2005
Global burden of liver disease: 2023 update
2023 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence
2011
Regulation of immune responses by extracellular vesicles
2014 Standout
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Donor evaluation and hepatectomy for living-donor liver transplantation
2008
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production
2015 StandoutNobel
Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver
2012
Type 2 diabetes mellitus
2015 Standout
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study
2003
Recurrent hepatitis C genotype 1b following liver transplantation
2004
Diagnosing norovirus-associated infectious intestinal disease using viral load
2009
Infection in Solid-Organ Transplant Recipients
2007 Standout
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
The option of HBIG-free prophylaxis against recurrent HBV
2012
Discordance Between ALT Values and Fibrosis in Liver Transplant Recipients Treated with Ribavirin for Recurrent Hepatitis C
2003
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation
2003
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis B
2007
Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function
2000
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Exosomes
2019 Standout
Nonalcoholic Steatohepatitis After Liver Transplantation
2019
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Pancreatic infection complicating acute pancreatitis
1993
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation
2004
Current Advances and Travails in Islet Transplantation
2009
Microvesicles Derived from Endothelial Progenitor Cells Enhance Neoangiogenesis of Human Pancreatic Islets
2012
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Towards a small animal model for hepatitis C
2009 StandoutNobel
Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides
2002 Standout
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
2011
Endothelial progenitor cell–derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA
2007
Chronic Viral Hepatitis and Hepatocellular Carcinoma
2007
Works of A Franchello being referenced
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
2005
Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin
2002
Ischemic Preconditioning (IP) of the Liver as a Safe and Protective Technique against Ischemia/Reperfusion Injury (IRI)
2009
Use of Hepatitis C Virus-Positive Grafts in Liver Transplantation: A Single-Centre Experience
2005
Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation
2001
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
2001
Outcome of patients transplanted with liver from hepatitis C positive donors
2001
Antiangiogenic and Immunomodulatory Effects of Rapamycin on Islet Endothelium: Relevance for Islet Transplantation
2006
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants
2005
Severe Course of Primary Hyperoxaluria and Renal Failure After Domino Hepatic Transplantation
2005
The first one thousand liver transplants in Turin: a single-center experience in Italy
2005
Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: Clinical significance
2004
Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation
2004
Platelet-Activating Factor Synthesis and Response on Pancreatic Islet Endothelial Cells: Relevance for Islet Transplantation
2006
Rupture of thoracic aorta resulting from blunt trauma.
1997
COBAS AmpliPrep-COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real-Time PCR Assay for Quantification of HBV DNA in Plasma
2007
New-Onset Diabetes After Liver Transplantation
2005
Beneficial effect of enhanced macrophage function in the trauma patient.
1990
124Treatment of recurrent hepatitis C after liver transplantation with interferon alfa 2B and ribavirin
2000